-+ 0.00%
-+ 0.00%
-+ 0.00%

Brookline Capital Downgrades Caribou Biosciences to Hold

Benzinga·10/07/2026 15:06:36
Listen to the news
Brookline Capital analyst Leah Cann downgrades Caribou Biosciences (NASDAQ:CRBU) from Buy to Hold.